Get started
Author

Nobumoto Tomioka

The therapeutic candidate for immune checkpoint inhibitors elucidated by the status of tumor-infiltrating lymphocytes (TILs) and programmed death ligand 1 (PD-L1) expression in triple negative breast cancer (TNBC)
2017 · Nobumoto Tomioka, Manabu Azuma, et al. · Breast Cancer · 106
Novel risk stratification of patients with neuroblastoma by genomic signature, which is independent of molecular signature
2007 · N Tomioka, S Oba, et al. · Oncogene · 82
Identification and characterization of a 500-kb homozygously deleted region at 1p36.2-p36.3 in a neuroblastoma cell line
2000 · Miki Ohira, Hajime Kageyama, et al. · Oncogene · 78
Efficacy, safety, and biomarker analysis of nivolumab in combination with abemaciclib plus endocrine therapy in patients with HR-positive HER2-negative metastatic breast cancer: a phase II study (WJOG11418B NEWFLAME trial)
2023 · Jun Masuda, Hitomi Sakai, et al. · Journal for ImmunoTherapy of Cancer · 76
PDF
Clinicopathological factors predicting early and late distant recurrence in estrogen receptor-positive, HER2-negative breast cancer
2015 · Hiroko Yamashita, Akiko Ogiya, et al. · Breast Cancer · 48
PDF
Associations in tumor infiltrating lymphocytes between clinicopathological factors and clinical outcomes in estrogen receptor‑positive/human epidermal growth factor receptor type 2 negative breast cancer
2018 · Yuichiro Miyoshi, Tadahiko Shien, et al. · Oncology Letters · 40
PDF
Differences in expression of the cancer stem cell marker aldehyde dehydrogenase 1 among estrogen receptor-positive/human epidermal growth factor receptor type 2-negative breast cancer cases with early, late, and no recurrence
2016 · Yuichiro Miyoshi, Tadahiko Shien, et al. · Breast Cancer Research · 35
PDF
Array comparative genomic hybridization analysis revealed four genomic prognostic biomarkers for primary gastric cancers
2010 · Nobumoto Tomioka, Keiko Morita, et al. · Cancer Genetics and Cytogenetics · 31
Post-relapse survival in patients with the early and late distant recurrence in estrogen receptor-positive HER2-negative breast cancer
2016 · Akiko Ogiya, Kieko Yamazaki, et al. · Breast Cancer · 22
PDF
Chromosomes that show partial loss or gain in near‐diploid tumors coincide with chromosomes that show whole loss or gain in near‐triploid tumors: Evidence suggesting the involvement of the same genes in the tumorigenesis of high‐ and low‐risk neuroblastomas
2002 · Nobumoto Tomioka, Hirofumi Kobayashi, et al. · Genes Chromosomes and Cancer · 20
Identification of the full-length KIAA0591 gene encoding a novel kinesin-related protein which is mapped to the neuroblastoma suppressor gene locus at 1p36.2.
2000 · M Nagai, S Ichimiya, et al. · International Journal of Oncology · 15
Gastric exclusion for unresectable gastric cancer.
1999 · Y Nakata, K Kimura, et al. · PubMed · 15
Publisher Correction: Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trial
2024 · Nadia Harbeck, Eva Ciruelos, et al. · Nature Medicine · 13
PDF
Biology of neuroblastomas that were found by mass screening at 6 months of age in Japan
2005 · Yasuhiko Kaneko, Hirofumi Kobayashi, et al. · Pediatric Blood & Cancer · 13
Real-World Predictors of Severe Neutropenia Associated with Palbociclib and Endocrine Therapy for Metastatic Breast Cancer in Japanese Patients
2023 · Shinya Takada, Hideki Maeda, et al. · Biological and Pharmaceutical Bulletin · 8
PDF
Clinical Management of Potential Toxicity of Abemaciclib and Approaches to Ensure Treatment Continuation
2023 · Shinya Takada, Hideki Maeda, et al. · Asian Pacific Journal of Cancer Prevention · 6
PDF
Two Cases of Intra-abdominal Desmoid Tumor
2008 · Hiroki SHOMURA, Akihiko KATAOKA, et al. · Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) · 5
PDF
Deep learning-based quantitative assessment of tumor-infiltrating lymphocytes from hematoxylin and eosin-stained slides in triple-negative breast cancer: A prognostic study.
2024 · Takuma Kobayashi, Kanako C Hatanaka, et al. · Journal of Clinical Oncology · 4
Significance of prostate/pancreatic/skin cancer family history for detecting BRCA2 pathogenic variant careers among patients with breast cancer
2022 · Yuko Minoura, Masato Takahashi, et al. · Breast Cancer · 4
Prediction of Severe Anemia and Neutropenia Induced by Abemaciclib in Patients With Breast Cancer
2025 · SHINYA TAKADA, KENGO UMEHARA, et al. · Anticancer Research · 3
Usefulness of Hospital and Community Pharmacists Collaborating to Manage Capecitabine-induced Severe Hand-foot Syndrome in Patients with Breast Cancer
2024 · Shinya Takada, Kengo Umehara, et al. · Asian Pacific Journal of Cancer Prevention · 3
PDF
Programmed death ligand 1-positive immune cells in primary tumor or metastatic axillary lymph nodes can predict prognosis of triple-negative breast cancer even when present at < 1% in the tumor region
2023 · Nobumoto Tomioka, Kanako C. Hatanaka, et al. · Breast Cancer · 3
PDF
AI-based quantification of TILs using hematoxylin and eosin and immunohistochemistry-stained slides in triple-negative breast cancer.
2024 · Takuma Kobayashi, Nobumoto Tomioka, et al. · Journal of Clinical Oncology · 2
Risk Factors for Eribulin-induced Severe Neutropenia in Patients With Recurrent Breast Cancer
2023 · SHINYA TAKADA, YOSHIHIRO HOSOKAWA, et al. · In Vivo · 2
PDF
A Case of Castleman's Disease of the Greater Omentum Treated by Laparoscopic Resection
2011 · Yosuke TSURUGA, Takahito NAKAGAWA, et al. · Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) · 2
PDF
Works count: 61
Citation count: 648
H-index: 13
I10-index: 14
Year
Topic
Type